Aptose Biosciences Inc.
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$0.23avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Aptose Biosciences Inc. in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Nations Financial Group Inc, /Ia/ ($4K) and Caldwell Sutter Capital, Inc. ($21).
- Company
- Aptose Biosciences Inc.
- CUSIP
- 03835T200
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 19,500 shares bought, net +19,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Nations Financial Group Inc, /Ia/ | 0.00% | New | 19,500 | $4K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 92 | $21 |
"% of holder's portfolio" is APTOSE BIOSCIENCES INC's weight in each manager's 13F, not the share of Aptose Biosciences Inc. the manager owns.